[Form 4] Snowflake Inc. Insider Trading Activity
Rhea-AI Filing Summary
Snowflake Inc. (SNOW) insider filing shows stock withholding and a plan-based sale by Benoit Dageville. The reporting person had restricted stock units vest and 1,011 and 939 shares were withheld on 9/15/2025 to satisfy tax obligations at a price of $221.15 per share. On 9/16/2025 the filing reports a sale of 1,912 shares at $221.24 per share executed under a 10b5-1 trading plan adopted March 28, 2025. After these transactions the filing lists 52,277 shares beneficially owned directly and additional indirect holdings of 750,000, 750,000 and 3,146,555 shares held in three trusts, with specific trustee relationships and a disclaimer of beneficial ownership for one trust.
Positive
- Sale executed under a 10b5-1 trading plan, indicating pre-established rules for transactions.
- Tax withholding on RSU vesting was reported, showing shares were surrendered to cover tax obligations.
- Detailed trustee disclosures specify which shares are held indirectly and include a disclaimer for one trust.
Negative
- Direct beneficial ownership decreased to 52,277 shares following withholding and sale transactions.
Insights
TL;DR: Insider sales were routine plan-based trades and tax-withholding on vested RSUs, moderately reducing direct holdings.
The Form 4 documents tax-withholding on RSU vesting (1,950 shares withheld across two entries) and a contemporaneous sale of 1,912 shares under a pre-established 10b5-1 plan. The per-share prices (~$221.15–$221.24) indicate transactions executed in close succession. Direct beneficial ownership remains 52,277 shares after the reported transactions, while substantial indirect positions are held in trusts (totaling 4,646,555 shares across three vehicles). For investors, these are disclosure items reflecting personal liquidity and estate planning rather than company operational developments.
TL;DR: Disclosure aligns with Section 16 reporting: RSU withholding, trustee arrangements, and 10b5-1 sale are properly reported.
The filing specifies the Reporting Person’s roles (director and President of Products) and lists both direct and indirect holdings with clear trustee notes and a disclaimer for one trust. The sale was executed under a documented 10b5-1 plan adopted March 28, 2025, which supports the affirmative defense language checked on the form. Signature by an attorney-in-fact is included. The record appears compliant with Form 4 requirements and provides relevant ownership transparency.